Founded in 2007, Klea Holding is a group focused on acquiring, developing and digitizing companies in various sectors to maximize their growth and value. Through its "scaling industries of the future" identity, Klea Holding draws on its successful experience in developing Smart Salem, the first network of digitalized medical analysis centers accredited by the Dubai Ministry of Health (DHA) in the United Arab Emirates, its joint venture Smart Health, dedicated to the roll-out of digital medical testing centres in Saudi Arabia; and Klea Pharmaceuticals, a subsidiary dedicated to the commercialisation of a portfolio of licensed medicines in the Middle East and Africa.

Employees

128

Sector

Healthcare Facilities & Services

More about the company

Quotes

Date	Price	Change
02/07/26	€0.1708	-1.50%
01/07/26	€0.1734	+2.60%
30/06/26	€0.1690	0.00%
29/06/26	€0.1690	-6.11%
26/06/26	€0.1800	+3.45%

Delayed Quote Deutsche Boerse AG

More quotes

Income Statement and Estimates

More financial data

Annual profits - Rate of surprise

Company calendar

Delayed Deutsche Boerse AG Other stock markets 10:01:23 02/07/2026 +04			5-day change	1st Jan Change
0.1708 ^EUR	-1.50%		-1.84%	-16.48%

06-11	Klea Holding SA Announces the Launch of Its New Subsidiary, Klea Pharmaceuticals	CI
06-11	Klea Launches Medicine Distribution Business for Middle East, Africa	MT

Market Cap	55.5M 63.52M 50.97M 47.53M 90.11M 6.05B 91.63M 614M 238M 2.97B 239M 233M 10.22B	P/E 2024	44.3x	P/E 2025	31.3x
Enterprise Value	55.63M 63.66M 51.08M 47.64M 90.31M 6.06B 91.83M 615M 238M 2.97B 239M 234M 10.24B	EV / Sales 2024	3.3x	EV / Sales 2025	3.04x
Free-Float	99.83%	Yield 2024 *	-	Yield 2025	-

06-11	Klea Holding SA Announces the Launch of Its New Subsidiary, Klea Pharmaceuticals	CI
06-11	Klea Launches Medicine Distribution Business for Middle East, Africa	MT
06-11	Klea Holding announces the launch of its new subsidiary
04-23	Klea Holding SA Reports Earnings Results for the Full Year Ended December 31, 2025	CI
04-01	Klea Holding Establishes Klea Pharmaceuticals and Expands Healthcare Operations in Middle East and Africa	CI
04-01	Klea Holding SA acquired New Licences and Pharmaceutical Assets for AED 8.5 million.	CI
01-19	Klea Holding Increases Annual Revenue by 28%
01-19	Klea Holding SA Reports Unaudited Consolidated Sales Results for the Year Ended December 31, 2025	CI
01-19	Klea Holding SA to Open First Digital Medical Centre in Saudi Arabia in March/April 2026	CI
27/10/25	Klea Holding Strengthens Its Presence in Dubai with Its First Strategic Real Estate Investment in the Lumena Alta Project	CI
27/10/25	Klea Holding Buys Office Space at Skyscraper Project in Dubai	MT
19/09/25	Klea Holding SA Reports Earnings Results for the Half Year Ended June 30, 2025	CI
18/08/25	Klea Holding SA commences an Equity Buyback Plan for 30,751,431 shares, representing 10% of its issued share capital for ?46.13 million, under the authorization approved on June 10, 2025.	CI

06-11	Klea Holding : Klea Pharmaceuticals launch its business with a strong partner	AT
04-23	Klea : reports record results in 2025 and demonstrates remarkable resilience in Q1 2026	PU
04-23	Klea Holding : Klea Holding reports record results in 2025 and demonstrates remarkable resilience in Q1 2026	AT
04-01	Klea Holding : Klea Holding is accelerating its diversification into the healthcare sector with the creation of Klea Pharmaceuticals	AT
01-19	Klea Holding : Klea Holding reports profitable growth of 34% in turnover in 2025 at constant exchange rates	AT

Klea Holding Stock Deutsche Boerse AG

Stocks

7V91

FR0013481835

Healthcare Facilities & Services

Valuation: Klea Holding

Chart: Klea Holding

Latest news : Klea Holding

Analysts' recommendations: Klea Holding

Press Releases: Klea Holding

News in other languages: Klea Holding

Quotes and Performance

Course Extremes

Managers and Directors: Klea Holding

Other Healthcare Facilities & Services

Financials

Company Profile

Quotes

Income Statement and Estimates

Annual profits - Rate of surprise

06-29	Klea Holding : Déclaration des transactions sur actions propres
06-12	Klea Holding : Déclaration des transactions sur actions propres
06-11	Bourse : J-1 avant SpaceX, Oracle à la peine, contrat pour Airbus
06-11	Klea Holding annonce le démarrage de sa nouvelle filiale
06-11	Une bonne grosse purge avant SpaceX

1 day	-1.50%
1 week	-1.84%
Current month	+1.07%
1 month	-8.66%
3 months	-2.95%
6 months	-19.62%
Current year	-16.48%

1 week	0.17	0.18
1 month	0.17	0.2
Current year	0.16	0.24
1 year	0.16	0.3
3 years	0.14	0.52
5 years	0.07	0.58
10 years	0	14.84

Manager	Title	Age	Since
Clement Pacaud CEO	Chief Executive Officer	36	22/01/2024
Jérôme Fabreguettes-Leib IRC	Investor Relations Contact	-	-
Thomas Picquette CEO	Chief Executive Officer	-	01/04/2022

Director	Title	Age	Since
Guillaume Bremond CHM	Chairman	-	-
Anne Gaignard BRD	Director/Board Member	-	01/04/2022
Paul Amsellem BRD	Director/Board Member	51	14/06/2023

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
KLEA HOLDING	-1.50%	-1.84%	-	-	63.22M
CVS HEALTH CORPORATION	-0.89%	-0.30%	+56.68%	+49.56%	134B
HCA HEALTHCARE, INC.	+4.83%	+6.91%	+9.43%	+39.02%	87.24B
FRESENIUS SE & CO. KGAA	+2.66%	+5.01%	-0.38%	+62.50%	26.32B
QUEST DIAGNOSTICS INCORPORATED	-0.22%	+4.52%	+22.06%	+54.92%	23.91B
DR. SULAIMAN AL HABIB MEDICAL SERVICES GROUP COMPANY	-0.83%	+0.05%	-21.86%	-25.19%	20.13B
TENET HEALTHCARE CORPORATION	+6.91%	+11.60%	+19.19%	+152.34%	16.47B
REDE D'OR SÃO LUIZ S.A.	+1.06%	+2.43%	+1.72%	+5.70%	14.78B
DAVITA INC.	+2.90%	+10.63%	+65.58%	+134.25%	14.64B
FRESENIUS MEDICAL CARE AG	+2.64%	+0.64%	-14.84%	-5.75%	12.26B
Average	+1.75%	+2.59%	+15.29%	+51.93%	38.83B
Weighted average by Cap.	+1.61%	+2.57%	+27.47%	+48.56%

	2024	2025
Net sales	17.26M 19.75M 15.85M 14.78M 28.02M 1.88B 28.49M 191M 73.96M 922M 74.17M 72.56M 3.18B	22.17M 25.37M 20.35M 18.98M 35.99M 2.41B 36.59M 245M 94.98M 1.18B 95.25M 93.18M 4.08B
Net income	1.4M 1.61M 1.29M 1.2M 2.28M 153M 2.32M 15.53M 6.02M 75.08M 6.04M 5.91M 259M	2.28M 2.61M 2.09M 1.95M 3.7M 249M 3.77M 25.22M 9.77M 122M 9.8M 9.59M 420M
Net Debt	2.58M 2.95M 2.36M 2.21M 4.18M 281M 4.25M 28.47M 11.03M 138M 11.07M 10.82M 474M	125K 143K 115K 107K 203K 13.62M 206K 1.38M 536K 6.68M 537K 525K 23.02M